Growth hormone dependent human serum stimulation of thymidine and sulphate incorporation into embryonic chicken cartilage
Abstract. The embryonic chicken cartilage somatomedin bioassay was modified so that human serum stimulation of simultaneous [3H]methylthymidine and H2[35S]04 incorporation could be assessed. The assay consisted of a 6 h pre-incubation of 10 day pelvic rudiments in enriched buffer, followed by a 24 h incubation with buffer and low (0.5, 2 and 5% v/v) serum concentrations. Both labels were present for the final 6 h. Other modifications were shortening of washing, elimination of drying and weighing, and simplification of digestion. Normal human serum produced a linear log dose-response with these serum concentrations. Potency ratios in patients with GH deficiency were less than those of normal adults for both thymidine 0.39 ± 0.05 (mean ± sem, n = 16, range 0.22-0.71) vs. 0.90 ± 0.05 (n = 19, 0.62—1.36, P< 0.001) and for sulphate 0.40 ± 0.04 (0.15—0.65) vs. 94 ± 0.05 (0.61—1.29, P< 0.001). Potency ratios for both labels rose following administration of a single dose (0.2 IU/kg im) of hGH to 4 GH deficient children. The reliability of prediction of GH deficiency, reproducibility, and precision were similar to other Sm bioassays. The major advantages of these modifications were the ability to examine 2 cartilage metabolic processes simultaneously and the small amount of serum (350 μl) necessary for patient assays.